Litigation Details for AbbVie Inc. v. Alkem Laboratories Limited (D. Del. 2022)
AbbVie Inc. v. Alkem Laboratories Limited (D. Del. 2022)
| Docket | ⤷ Start Trial | Date Filed | 2022-10-27 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Jennifer L. Hall |
| Jury Demand | None | Referred To | |
| Parties | NEUROCRINE BIOSCIENCES, INC. | ||
| Patents | 10,537,572; 10,682,351; 11,344,551; 11,542,239; 11,690,845; 11,690,854; 7,056,927; 7,176,211; 7,419,983 | ||
| Attorneys | Deirdre M. Wells | ||
| Firms | Devlin Law Firm LLC | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in AbbVie Inc. v. Alkem Laboratories Limited
Details for AbbVie Inc. v. Alkem Laboratories Limited (D. Del. 2022)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2022-10-27 | External link to document | |||
| 2022-10-27 | 12 | Patent/Trademark Report to Commissioner of Patents | ;7,176,211 B2 ;7,419,983 B2 ;10,537,572 B2 ;10,682,351 B2 ;11,344,551 B2. (vfm) (Entered: 10/28/2022)… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,056,927 B2 ;… 27 October 2022 1:22-cv-01423 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2022-10-27 | 163 | Notice of Service | Solco Healthcare US, LLC for U.S. Patent Nos. 11,542,239, 10,537,572, and 10,682,351; (4) Plaintiffs' …Contentions Against Alkem Laboratories Limited for U.S. Patent No. 11,542,239; (2) Plaintiffs' Initial Infringement…Labs Limited Unit-V, and Hetero USA Inc. for U.S. Patent No. 11,542,239; (3) Plaintiffs' Initial Infringement… Sun Pharmaceutical Industries Limited for U.S. Patent No. 11,542,239; and (5) Plaintiffs' Initial Infringement…Biophore India Pharmaceuticals Private Ltd. for U.S. Patent No. 11,542,239 filed by AbbVie Inc., AbbVie Ltd | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
